This breakthrough, which is a first in the Triad, offers a new option for patients with severe tricuspid regurgitation, a ...

Surgeons at Gleneagles Hospitals successfully performed Transcatheter Tricuspid Valve Edge-to-Edge Repair on a 75-year-old ...

PARIS, France—Percutaneous edge-to-edge repair with a clip device appears to offer some hope for patients with tricuspid regurgitation, according to new results from the TRILUMINATE study. At 30 days, ...

Tricuspid valve (TV) disease most often occurs secondary to left-sided heart disease, particularly mitral valve (MV) regurgitation or stenosis. Appropriate treatment, even when TV regurgitation is ...

Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who received a novel investigational device intended to repair the defective valve experienced ...

Henry Ford Health cardiologists are the first to offer new Tri-Clip procedure to patients for whom open-heart surgery isn’t an option A breakthrough in treating tricuspid regurgitation, or TR, is ...

VDyne Inc. ("VDyne"), a privately held medical device company developing a transcatheter tricuspid valve replacement (TTVR) system to treat tricuspid regurgitation, today announced the appointment of ...

An estimated 1.6 million Americans suffer moderate to severe leakage through their tricuspid valves, which are complex structures that allow blood to flow from the heart's upper right chamber to the ...

CHICAGO -- Champions of tricuspid transcatheter edge-to-edge repair (TEER) were buoyed by 2-year results of the TRILUMINATE trial marking the first report of reduced heart failure (HF) hospitalization ...

The FDA approved the Evoque tricuspid valve replacement system as the first transcatheter treatment for tricuspid regurgitation (TR), Edwards Lifesciences announced. Evoque gained an indication for ...